Related Experiment Video
Updated: Aug 16, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
Large artery compliance in essential hypertension. Effects of calcium antagonism and beta-blocking
R De Cesaris1, G Ranieri, V Filitti
1Department of Biomedical Science and Human Oncology, University of Bari Medical School, Italy.
Insights
Nicardipine treatment improved forearm hemodynamics and arterial compliance in hypertensive patients, with lasting effects even after therapy cessation. Atenolol did not yield significant hemodynamic changes.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Hypertension Research
Background:
- Essential hypertension is a prevalent cardiovascular condition.
- Peripheral hemodynamic alterations are characteristic of hypertension.
- Understanding drug effects on vascular function is crucial for treatment.
Purpose of the Study:
- To evaluate the impact of nicardipine and atenolol on peripheral hemodynamics in hypertensive patients.
- To assess the persistence of hemodynamic changes after drug withdrawal.
- To investigate nicardipine's potential to induce arterial regression.
Main Methods:
- 2D Doppler flowmetry was used to measure hemodynamic parameters.
- Forty patients with mild to moderate essential hypertension were treated for 8 months.
- Responder patients were monitored for 4 weeks post-therapy suspension.
Main Results:
- Both nicardipine and atenolol lowered blood pressure.
- Nicardipine significantly increased arterial diameter and compliance, while decreasing pulse wave velocity and resistance.
- Atenolol did not produce significant changes in these hemodynamic parameters.
- Hemodynamic improvements in the nicardipine group persisted after therapy cessation.
Conclusions:
- Nicardipine effectively improves peripheral hemodynamics and arterial compliance in hypertensive patients.
- These beneficial effects on forearm hemodynamics may persist after nicardipine discontinuation.
- Nicardipine might induce regression of functional and/or structural arterial changes in hypertension.
Abstract:
This study used 2D Doppler flowmetry to assess the effects on peripheral hemodynamics of effective treatment with nicardipine or atenolol in 40 patients with mild or moderate essential hypertension. Two groups of 20 patients received treatment with nicardipine or atenolol, respectively, for 8 months. Consequently, those patients considered to be responders (blood pressure less than 150/90 mm Hg) were monitored for another 4 weeks after the therapy was suspended in order to determine whether the changes, if any, in arterial compliance persisted. Following the 8-month therapy, four patients from each group were excluded from the study because of unsatisfactory blood pressure levels. After the treatment, there was a decrease in blood pressure in both groups (P less than .01). In the nicardipine group, there was a significant increase in diameter and compliance (P less than .01), whereas pulse wave velocity and resistance decreased (P less than .01). In the atenolol group, these parameters did not change significantly. After therapy was ended, blood pressure returned to baseline values in both groups. However, in the nicardipine group, the observed improvement in forearm hemodynamics persisted. This result may indicate that nicardipine is able to induce a regression of functional and/or structural changes in the large arteries of hypertensive patients.
More Related Videos
08:08Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
Published on: June 10, 2015
10:28Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
Published on: December 5, 2017
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Types of β-Blockers
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers